PT  - JOURNAL ARTICLE
AU  - Aisling M. O’Halloran
AU  - Peter Hartley
AU  - David Moloney
AU  - Christine McGarrigle
AU  - Rose Anne Kenny
AU  - Roman Romero-Ortuno
TI  - Informing patterns of health and social care utilisation in Irish older people according to the Clinical Frailty Scale
AID  - 10.1101/2021.04.21.21255882
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.21.21255882
4099  - http://medrxiv.org/content/early/2021/04/27/2021.04.21.21255882.short
4100  - http://medrxiv.org/content/early/2021/04/27/2021.04.21.21255882.full
AB  - There is increasing policy interest in the consideration of frailty measures (rather than chronological age alone) to inform a more equitable allocation of health and social care resources in the community. The Clinical Frailty Scale (CFS) has attracted interest for its simplicity and consideration of multiple relevant geriatric dimensions. However, a criticism of the CFS has been the possible subjectivity in the scoring, bringing the possible danger of lack of scoring consistency across agencies. For that reason, the authors of the CFS published a classification tree method to assist with routine scoring of the CFS.The aim of the present study was to apply the CFS classification tree to data from adults aged 65 and over from The Irish Longitudinal Study on Ageing (TILDA) and correlate derived CFS categories with patterns of health and social care utilisation in Irish older people assessed in Wave 5 of the study (year 2018). In addition, we explored how CFS categories and states changed over 8 years in TILDA between Wave 1 (2010) and Wave 5.Results showed the following prevalence of CFS categories in Wave 5: 6% ‘very fit’ (CFS1), 36% ‘fit’ (CFS2), 31% ‘managing well’ (CFS3), 16% ‘vulnerable’ (CFS4), 6% ‘mildly frail’ (CFS5), 4% ‘moderately frail’ (CFS6) and 1% ‘severely frail’ (CFS7). No participants were ‘very severely frail’ or ‘terminally ill’. In wave 5, increasing CFS categories had an association with increasing utilisation of hospital and community health services, and increasing hours of formal and informal social care provision. The transitions analyses from Wave 1 to 5 suggested a dynamic picture of CFS transitions, with 2-year probability of transitioning from ‘fit’ (CFS1-3) to ‘vulnerable’ (CFS4), and ‘fit’ to ‘frail’ (CFS5+) at 34% and 6%, respectively. ‘Vulnerable’ and ‘frail’ had a 22% and 17% probability of reversal to ‘fit’ and ‘vulnerable’, respectively.Our results suggest that the CFS classification tree was able to stratify the TILDA population aged 65 and over into subgroups with increasing health and social care needs. The CFS classification tree could be used to aid the allocation of health and social care resources in older people in Ireland, but given the frequency of CFS transitions in the population, it is recommended that CFS status in individuals is reviewed at least every 2 years.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTILDA is funded by Atlantic Philanthropies, the Irish Department of Health and Irish Life. RRO is funded by a Grant from Science Foundation Ireland under Grant number 18/FRL/6188. The funders had no role in the conduct of the research and/or preparation of the article; in study design; in the collection, analysis and interpretation of data; in writing of the report; or in the decision to submit the paper for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for each wave was obtained from the Faculty of Health Sciences Research Ethics Committee at Trinity College Dublin, Ireland. All participants provided written informed consent prior to inclusion in the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTILDA data access information can be accessed on: https://tilda.tcd.ie/data/accessing-data/. Data utilised in this study can be made accessible on reasonable request. https://tilda.tcd.ie/data/accessing-data/